131 related articles for article (PubMed ID: 24893613)
1. Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion.
Franco R; Zappavigna S; Gigantino V; Luce A; Cantile M; Cerrone M; Facchini G; Perdonà S; Pignata S; Di Lorenzo G; Chieffi S; Vitale G; De Sio M; Sgambato A; Botti G; Yousif AM; Novellino E; Grieco P; Caraglia M
J Exp Clin Cancer Res; 2014 Jun; 33(1):48. PubMed ID: 24893613
[TBL] [Abstract][Full Text] [Related]
2. Hedgehog pathway activation in human transitional cell carcinoma of the bladder.
Pignot G; Vieillefond A; Vacher S; Zerbib M; Debre B; Lidereau R; Amsellem-Ouazana D; Bieche I
Br J Cancer; 2012 Mar; 106(6):1177-86. PubMed ID: 22361633
[TBL] [Abstract][Full Text] [Related]
3. STAG2 as a prognostic biomarker in low-grade non-muscle invasive bladder cancer.
Taber A; Park Y; Lelo A; Prip F; Xiao J; Berry DL; Chaldekas K; Jensen JB; Philips G; Kim JS; Harris BT; Dyrskjøt L; Waldman T
Urol Oncol; 2021 Jul; 39(7):438.e1-438.e9. PubMed ID: 33712344
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Power of a Tumor Differentiation Gene Signature for Bladder Urothelial Carcinomas.
Mo Q; Nikolos F; Chen F; Tramel Z; Lee YC; Hayashi K; Xiao J; Shen J; Chan KS
J Natl Cancer Inst; 2018 May; 110(5):448-459. PubMed ID: 29342309
[TBL] [Abstract][Full Text] [Related]
5. Presence, Subtypes, and Prognostic Significance of Tertiary Lymphoid Structures in Urothelial Carcinoma of the Bladder.
Ma G; Jia H; Zhang G; Liang Y; Dong X; Fu G; Wang X; Niu H
Oncologist; 2024 Feb; 29(2):e248-e258. PubMed ID: 37874923
[TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of urinary bladder cancer susceptibility loci.
Grotenhuis AJ; Dudek AM; Verhaegh GW; Witjes JA; Aben KK; van der Marel SL; Vermeulen SH; Kiemeney LA
PLoS One; 2014; 9(2):e89164. PubMed ID: 24586564
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics analysis reveals distinct profiles of nonmuscle-invasive and muscle-invasive bladder cancer.
Sahu D; Lotan Y; Wittmann B; Neri B; Hansel DE
Cancer Med; 2017 Sep; 6(9):2106-2120. PubMed ID: 28766915
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis.
Gazzaniga P; Gradilone A; de Berardinis E; Busetto GM; Raimondi C; Gandini O; Nicolazzo C; Petracca A; Vincenzi B; Farcomeni A; Gentile V; Cortesi E; Frati L
Ann Oncol; 2012 Sep; 23(9):2352-2356. PubMed ID: 22351740
[TBL] [Abstract][Full Text] [Related]
9. Glycoprotein nonmetastatic melanoma protein B impacts the malignant potential of bladder cancer cells through its hem-immunoreceptor tyrosine-based activation motif.
Kimura T; Okita Y; Nagumo Y; Chin JM; Fikry MA; Shiga M; Kandori S; Kawahara T; Suzuki H; Nishiyama H; Kato M
Pathol Int; 2024 May; 74(5):262-273. PubMed ID: 38501371
[TBL] [Abstract][Full Text] [Related]
10. STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder Cancer.
Lelo A; Prip F; Harris BT; Solomon D; Berry DL; Chaldekas K; Kumar A; Simko J; Jensen JB; Bhattacharyya P; Mannion C; Kim JS; Philips G; Dyrskjøt L; Waldman T
Clin Cancer Res; 2018 Sep; 24(17):4145-4153. PubMed ID: 29954776
[No Abstract] [Full Text] [Related]
11. Positive association of collagen type I with non-muscle invasive bladder cancer progression.
Brooks M; Mo Q; Krasnow R; Ho PL; Lee YC; Xiao J; Kurtova A; Lerner S; Godoy G; Jian W; Castro P; Chen F; Rowley D; Ittmann M; Chan KS
Oncotarget; 2016 Dec; 7(50):82609-82619. PubMed ID: 27655672
[TBL] [Abstract][Full Text] [Related]
12. The bladder microbiome of NMIBC and MIBC patients revealed by 2bRAD-M.
Sun JX; Xia QD; Zhong XY; Liu Z; Wang SG
Front Cell Infect Microbiol; 2023; 13():1182322. PubMed ID: 37351184
[TBL] [Abstract][Full Text] [Related]
13. Identification of STAG2-Mutant Bladder Cancers by Immunohistochemistry.
Park Y; Lelo A; Harris B; Berry DL; Chaldekas K; Kim JS; Waldman T
Methods Mol Biol; 2023; 2684():145-151. PubMed ID: 37410232
[TBL] [Abstract][Full Text] [Related]
14. The long noncoding RNA SUMO1P3 as urinary biomarker for monitoring bladder cancer progression.
Galbiati S; Bettiga A; Colciago G; Senti C; Trevisani F; Villa G; Marzinotto I; Ghidini M; Passalacqua R; Montorsi F; Salonia A; Vago R
Front Oncol; 2024; 14():1325157. PubMed ID: 38846969
[TBL] [Abstract][Full Text] [Related]
15. A mediation analysis to explain socio-economic differences in bladder cancer survival.
Russell B; Hemelrijck MV; Gårdmark T; Holmberg L; Kumar P; Bellavia A; Häggström C
Cancer Med; 2020 Oct; 9(20):7477-7487. PubMed ID: 32851811
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin-4 promotes bladder cancer cell migration and invasion via MMP2 production.
Chou KY; Chang AC; Ho CY; Tsai TF; Chen HE; Chen PC; Hwang TI
J Cell Mol Med; 2021 Jun; 25(13):6046-55. PubMed ID: 34142438
[TBL] [Abstract][Full Text] [Related]
17. Identifying non-muscle-invasive and muscle-invasive bladder cancer based on blood serum surface-enhanced Raman spectroscopy.
Chen S; Zhu S; Cui X; Xu W; Kong C; Zhang Z; Qian W
Biomed Opt Express; 2019 Jul; 10(7):3533-3544. PubMed ID: 31467792
[TBL] [Abstract][Full Text] [Related]
18. Reconstructing Phylogenetic Relationship in Bladder Cancer: A Methodological Overview.
Seillier L; Peifer M
Methods Mol Biol; 2023; 2684():113-132. PubMed ID: 37410230
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic Androgen Receptor, CD24 Expression and Smoking Intensity to Urothelial Carcinoma of the Bladder Invasiveness: A Cross-Sectional Study.
Pramod SV; Safriadi F; Hernowo BS; Dwiyana RF; Trianasari N; Egawa S
Res Rep Urol; 2023; 15():485-494. PubMed ID: 37933300
[TBL] [Abstract][Full Text] [Related]
20. Regarding the role of HER2 overexpression on the survival in muscle-invasive bladder cancer.
Yang W; Liu J
Int J Surg; 2024 Apr; 110(4):2466. PubMed ID: 38241347
[No Abstract] [Full Text] [Related]
[Next] [New Search]
